Norway
Research Article
Aggressive Treatment of Brain Metastasis Increases Survival in Patients with Lung Cancer
Author(s): Peter Hatlen, Tore Amundsen, Sveinung Sørhaug, Håkon Leira, Müller Tomm B, Ruby Mahesparan and Harald H HjeldePeter Hatlen, Tore Amundsen, Sveinung Sørhaug, Håkon Leira, Müller Tomm B, Ruby Mahesparan and Harald H Hjelde
Introduction: In selected patients superior survival has been observed when treated aggressively for lung cancer and brain metastasis (BM). The aim of the study was to evaluate treatment-modalities and survival in our region retrospective.
Method: Retrospectively we compared survival for lung cancer patients treated either with microsurgery or Gamma knife surgery (GKS) for BM to a control group (N=510) patients with lung cancer stage IV and a mean age of 68 years.
Results: 42 patients with non-small cell lung cancer were included, 22 (52%) treated with microsurgery and 20 (45%) with GKS for BM. Patients treated aggressively for lung cancer and BM had a significant survival-benefit, 21 months (CI 95%: 9.4-32.6) vs. 4 months in the control group (CI 95%: 3.5-4.5) (p<0.001). Treatment with microsurgery showed a survival-benefit com.. Read More»
DOI:
10.4172/2161-105X.1000271
Pulmonary & Respiratory Medicine received 1690 citations as per Google Scholar report